People across the world are mourning the death of Apple co-founder
Steve Jobs, who passed away Wednesday, Oct 5, following a battle with
pancreatic cancer. Jobs' death has turned attention to rare form of
cancer, for which the U.S. Food and Drug Administration this May
approved a new drug - the first new option in nearly 30 years. Learn
more about the drug, everolimus, and how it's helping patients with
pancreatic neuroendocrine tumors...